STOCK OPTIONS - Summary of Unvested Stock Option Activity (Details) - Common Stock - USD ($) |
3 Months Ended | 12 Months Ended |
|---|---|---|
Mar. 31, 2020 |
Dec. 31, 2019 |
|
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
| Beginning Balance, number of shares | 1,053,333 | |
| Options Granted, number of shares | 225,000 | |
| Ending Balance, number of shares | 1,278,333 | 1,053,333 |
| Beginning Balance, Weighted-average exercise price | $ 1.43 | |
| Granted, Weighted-average exercise price | 1.93 | |
| Ending Balance, Weighted-average exercise price | $ 1.51 | $ 1.43 |
| Aggregate intrinsic value | $ (849,066) | $ 357,734 |
| Weighted-average remaining contractual term (years) | 3 years 10 months 17 days | 3 years 11 months 1 day |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non vested options outstanding intrinsic value. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award options non vested outstanding weighted average remaining contractual term. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. No definition available.
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of non-vested options outstanding. No definition available.
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of non-vested options outstanding. No definition available.
|
| X | ||||||||||
- Details
|